BioLineRx to Report First Quarter 2025 Results on May 27, 2025
BioLineRx (NASDAQ: BLRX), a development stage biopharmaceutical company focused on oncology and rare diseases, has scheduled the release of its Q1 2025 unaudited financial results for May 27, 2025, before U.S. markets open.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
BioLineRx (NASDAQ: BLRX), a development stage biopharmaceutical company focused on oncology and rare diseases, has scheduled the release of its Q1 2025 unaudited financial results for May 27, 2025, before U.S. markets open. The company will host a conference call at 8:30 a.m. EDT featuring CEO Philip Serlin.
Investors can access the call via U.S. dial-in (+1-888-281-1167) or international dial-in (+972-3-918-0685). A live webcast and replay will be available through the company's website, with a dial-in replay accessible until May 29, 2024.
Details
News Market Reaction – BLRX
The recorded move for BLRX in the trading session of this news was +11.34%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Management to Hold Conference Call at 8:30 a.m. EDT
The Company will host a conference call at 8:30 a.m. EDT featuring remarks by Philip Serlin, Chief Executive Officer.
To access the conference call, please dial +1-888-281-1167 from the
About BioLineRx
BioLineRx Ltd. (NASDAQ/TASE: BLRX) is a biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases. The Company's first approved product is APHEXDA® (motixafortide), with an indication in the
Learn more about who we are, what we do, and how we do it at www.biolinerx.com, or on Twitter and LinkedIn. and events.
Logo: https://mma.prnewswire.com/media/2154863/BioLineRx_Ltd_Logo.jpg
Contacts:
Irina Koffler
LifeSci Advisors, LLC
IR@biolinerx.com
Moran Meir
LifeSci Advisors, LLC
moran@lifesciadvisors.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/biolinerx-to-report-first-quarter-2025-results-on-may-27-2025-302460229.html
SOURCE BioLineRx Ltd.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.